News

Bringing physicians a new degree of control and conformability

Gore ASSURED Clinical Study results through 36 months demonstrate 100 percent closure success^*

W. L. Gore & Associates (Gore) announces FDA approval of an expanded indication for the GORE^®...

With improvements to the stent graft delivery system enabling a 1 Fr profile reduction  on the...

First off-the-shelf solution for treatment of complex aneurysmal disease involving the visceral...

This study aims to compare the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis primary...

The first patient implant in the ARISE II Pivotal Study evaluation of the GORE® Ascending Stent...

The Gore RELIEF Clinical Study is evaluating the safety and efficacy of transcatheter closure of...

The Gore VBX FORWARD Clinical Study aims to compare the VBX Stent Graft primary patency to bare...

FIRST U.S. PATIENT ENROLLED IN GORE® VIAFORT VASCULAR STENT ILIOFEMORAL PIVOTAL STUDY